FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100265290> ?p ?o ?g. }

• W3100265290 endingPage "e22307" @default.
• W3100265290 startingPage "e22307" @default.
• W3100265290 abstract "Although secure messaging (SM) between patients and clinical team members is a recommended component of continuous care, uptake by patients remains relatively low. We designed a multicomponent Supported Adoption Program (SAP) to increase SM adoption among patients using the Veterans Health Administration (VHA) for primary care.Our goals were to (1) conduct a multisite, randomized, encouragement design trial to test the effectiveness of an SAP designed to increase patient engagement with SM through VHA's online patient portal (My HealtheVet [MHV]) and (2) evaluate the impact of the SAP and patient-level SM adoption on perceived provider autonomy support and communication. Patient-reported barriers to SM adoption were also assessed.We randomized 1195 patients at 3 VHA facilities who had MHV portal accounts but had never used SM. Half were randomized to receive the SAP, and half served as controls receiving usual care. The SAP consisted of encouragement to adopt SM via mailed educational materials, proactive SM sent to patients, and telephone-based motivational interviews. We examined differences in SM adoption rates between SAP recipients and controls at 9 months and 21 months. Follow-up telephone surveys were conducted to assess perceived provider autonomy support and self-report of telephone communication with clinical teams.Patients randomized to the SAP had significantly higher rates of SM adoption than the control group (101/595, 17.0% vs 40/600, 6.7%; P<.001). Most adopters in the SAP sent their first message without a motivational interview (71/101, 70.3%). The 10-percentage point difference in adoption persisted a full year after the encouragement ended (23.7%, 142/600 in the SAP group vs 13.5%, 80/595 in the control group, P<.001). We obtained follow-up survey data from 49.54% (592/1195) of the participants. SAP participants reported higher perceived provider autonomy support (5.7 vs 5.4, P=.007) and less telephone use to communicate with their provider (68.8% vs 76.0%, P=.05), compared to patients in the control group. Patient-reported barriers to SM adoption included self-efficacy (eg, not comfortable using a computer, 24%), no perceived need for SM (22%), and difficulties with portal password or login (17%).The multicomponent SAP was successful in increasing use of SM 10 percentage points above standard care; new SM adopters reported improved perceptions of provider autonomy support and less use of the telephone to communicate with their providers. Still, despite the encouragement and technical assistance provided through the SAP, adoption rates were lower than anticipated, reaching only 24% at 21 months (10% above controls). Common barriers to adoption such as limited perceived need for SM may be more challenging to address and require different interventions than barriers related to patient self-efficacy or technical difficulties.ClinicalTrials.gov NCT02665468; https://clinicaltrials.gov/ct2/show/NCT02665468." @default.
• W3100265290 created "2020-11-23" @default.
• W3100265290 creator A5027333876 @default.
• W3100265290 creator A5036574525 @default.
• W3100265290 creator A5052273482 @default.
• W3100265290 creator A5054494932 @default.
• W3100265290 creator A5054977155 @default.
• W3100265290 creator A5056275431 @default.
• W3100265290 creator A5056415972 @default.
• W3100265290 creator A5056454137 @default.
• W3100265290 creator A5060433059 @default.
• W3100265290 creator A5082654677 @default.
• W3100265290 creator A5088248616 @default.
• W3100265290 creator A5089329547 @default.
• W3100265290 date "2020-11-18" @default.
• W3100265290 modified "2023-10-01" @default.
• W3100265290 title "Impact of Patient-Clinical Team Secure Messaging on Communication Patterns and Patient Experience: Randomized Encouragement Design Trial" @default.
• W3100265290 cites W1521463631 @default.
• W3100265290 cites W1879300319 @default.
• W3100265290 cites W1895752644 @default.
• W3100265290 cites W1984430293 @default.
• W3100265290 cites W1984894067 @default.
• W3100265290 cites W1986967880 @default.
• W3100265290 cites W2000854673 @default.
• W3100265290 cites W2004643894 @default.
• W3100265290 cites W2008150938 @default.
• W3100265290 cites W2011210303 @default.
• W3100265290 cites W2037861128 @default.
• W3100265290 cites W2050353654 @default.
• W3100265290 cites W2057789619 @default.
• W3100265290 cites W2079278511 @default.
• W3100265290 cites W2100509572 @default.
• W3100265290 cites W2118836610 @default.
• W3100265290 cites W2139497806 @default.
• W3100265290 cites W2147197455 @default.
• W3100265290 cites W2147621655 @default.
• W3100265290 cites W2152066760 @default.
• W3100265290 cites W2154168106 @default.
• W3100265290 cites W2163433701 @default.
• W3100265290 cites W2217192022 @default.
• W3100265290 cites W2316792303 @default.
• W3100265290 cites W2463803708 @default.
• W3100265290 cites W2587816491 @default.
• W3100265290 cites W2599795825 @default.
• W3100265290 cites W2604684863 @default.
• W3100265290 cites W2750488214 @default.
• W3100265290 cites W2947493504 @default.
• W3100265290 cites W3027801844 @default.
• W3100265290 cites W4232375814 @default.
• W3100265290 doi "https://doi.org/10.2196/22307" @default.
• W3100265290 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7710447" @default.
• W3100265290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33206052" @default.
• W3100265290 hasPublicationYear "2020" @default.
• W3100265290 type Work @default.
• W3100265290 sameAs 3100265290 @default.
• W3100265290 citedByCount "5" @default.
• W3100265290 countsByYear W31002652902021 @default.
• W3100265290 countsByYear W31002652902022 @default.
• W3100265290 countsByYear W31002652902023 @default.
• W3100265290 crossrefType "journal-article" @default.
• W3100265290 hasAuthorship W3100265290A5027333876 @default.
• W3100265290 hasAuthorship W3100265290A5036574525 @default.
• W3100265290 hasAuthorship W3100265290A5052273482 @default.
• W3100265290 hasAuthorship W3100265290A5054494932 @default.
• W3100265290 hasAuthorship W3100265290A5054977155 @default.
• W3100265290 hasAuthorship W3100265290A5056275431 @default.
• W3100265290 hasAuthorship W3100265290A5056415972 @default.
• W3100265290 hasAuthorship W3100265290A5056454137 @default.
• W3100265290 hasAuthorship W3100265290A5060433059 @default.
• W3100265290 hasAuthorship W3100265290A5082654677 @default.
• W3100265290 hasAuthorship W3100265290A5088248616 @default.
• W3100265290 hasAuthorship W3100265290A5089329547 @default.
• W3100265290 hasBestOaLocation W31002652901 @default.
• W3100265290 hasConcept C126322002 @default.
• W3100265290 hasConcept C159110408 @default.
• W3100265290 hasConcept C160735492 @default.
• W3100265290 hasConcept C162324750 @default.
• W3100265290 hasConcept C168563851 @default.
• W3100265290 hasConcept C17744445 @default.
• W3100265290 hasConcept C199539241 @default.
• W3100265290 hasConcept C2775944032 @default.
• W3100265290 hasConcept C2776153502 @default.
• W3100265290 hasConcept C50522688 @default.
• W3100265290 hasConcept C512399662 @default.
• W3100265290 hasConcept C65414064 @default.
• W3100265290 hasConcept C71924100 @default.
• W3100265290 hasConceptScore W3100265290C126322002 @default.
• W3100265290 hasConceptScore W3100265290C159110408 @default.
• W3100265290 hasConceptScore W3100265290C160735492 @default.
• W3100265290 hasConceptScore W3100265290C162324750 @default.
• W3100265290 hasConceptScore W3100265290C168563851 @default.
• W3100265290 hasConceptScore W3100265290C17744445 @default.
• W3100265290 hasConceptScore W3100265290C199539241 @default.
• W3100265290 hasConceptScore W3100265290C2775944032 @default.
• W3100265290 hasConceptScore W3100265290C2776153502 @default.
• W3100265290 hasConceptScore W3100265290C50522688 @default.
• W3100265290 hasConceptScore W3100265290C512399662 @default.
• W3100265290 hasConceptScore W3100265290C65414064 @default.

• next